Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.48 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.48 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107687 | 1.00 | APP (0.52) | APPCA12CA1CA2CA7 | |
| SCHEMBL12047533 | 1.00 | APP (0.52) | APPCA12CA1CA2CA7 | |
| SCHEMBL29711827 | 0.89 | APP (0.48) | APPCA12CA1CA2CA7 | |
| Phenol SCHEMBL28658722 | 0.85 | PAM (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL23728175 | 0.82 | APP (0.59) | APPCA12CA1CA2CA7 | |
| SCHEMBL450882 | 0.82 | APP (0.48) | APPCA12CA1CA2CA7 | |
| SCHEMBL450883 | 0.82 | APP (0.48) | APPCA12CA1CA2CA7 | |
| SCHEMBL1888738 | 0.79 | TNNC1 (0.47) | APPCA12CA1CA2CA7 | |
| SCHEMBL8408465 | 0.79 | TNNC1 (0.47) | APPCA12CA1CA2CA7 | |
| SCHEMBL28676741 | 0.78 | TYR (0.71) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| JP-6040982-A | — | — | None | — | — | JP | disclosed |
| JP-6234683-A | — | — | None | — | — | JP | disclosed |
| JP-7109242-A | — | — | None | — | — | JP | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| CN-222231028-U | Cooling device is used in divinylbenzene preparation | 宁夏宝运新材料科技有限公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-118634859-A | Cu/HZSM-5 molecular sieve, preparation thereof and application thereof in raspberry ketone synthesis | 上海应用技术大学 | 2024-09-13 | — | — | CN | disclosed |
| EP-0179532-B1 | PERFUME COMPOSITION AND PERFUMED PRODUCTS WHICH CONTAIN ONE OR MORE O-ALKOXYPHENOLS AS PERFUME COMPONENT | NAARDEN INTERNATIONAL N.V. (NL) | 1987-08-19 | — | — | EP | disclosed |
| EP-0161132-B1 | PROCESS FOR THE SELECTIVE C-ALKYLATION OF PHENOLS | RHONE-POULENC SANTE (FR) | 1987-05-20 | — | — | EP | disclosed |
| US-4650604-A | VANILLA | NAARDEN INTERNATIONAL N. V. (NL) | 1987-03-17 | — | — | US | disclosed |
| US-4594460-A | Process for selective C-alkylation of phenols | RHONE-POULENC SANTE (FR) | 1986-06-10 | — | — | US | disclosed |
| EP-0179532-A1 | Perfume composition and perfumed products which contain one or more o-alkoxyphenols as perfume component | NAARDEN INTERNATIONAL N.V. (NL) | 1986-04-30 | — | — | EP | disclosed |
| EP-0161132-A1 | Process for the selective C-alkylation of phenols | RHONE-POULENC SANTE (FR) | 1985-11-13 | — | — | EP | disclosed |
| US-4035559-A | CROSSLINKING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | APP 1457/4885CA12 1601/4885CA1 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.